Non-invasive tests accurately stratify patients with NAFLD based on their risk of liver-related events

Diagnostic accuracy of non-invasive tests for advanced fibrosis in patients with NAFLD: an individual patient data meta-analysis

(2021) Ferenc Emil Mózes et al.   GUT

Association Between Fibrosis Stage and Outcomes of Patients with Non-Alcoholic Fatty Liver Disease: a Systematic Review and Meta-Analysis

(2020) Rod S. Taylor et al.   GASTROENTEROLOGY

Cost Effectiveness of Different Strategies for Detecting Cirrhosis in Patients With Non-alcoholic Fatty Liver Disease Based on United States Health Care System

(2020) Eduardo Vilar-Gomez et al.   Clinical Gastroenterology and Hepatology

Non-invasive diagnosis of patients with ‘at-risk’ NAFLD : only fibrosis counts?

(2020) Andreas Geier et al.   GUT

Enhanced liver fibrosis test for the non-invasive diagnosis of fibrosis in patients with NAFLD: A systematic review and meta-analysis

(2020) Yasaman Vali et al.   JOURNAL OF HEPATOLOGY

Suboptimal reliability of liver biopsy evaluation has implications for randomized clinical trials

(2020) Beth A. Davison et al.   JOURNAL OF HEPATOLOGY

Repeated FIB-4 measurements can help identify individuals at risk of severe liver disease

(2020) Hannes Hagström et al.   JOURNAL OF HEPATOLOGY

Refining the Baveno VI elastography criteria for the definition of compensated advanced chronic liver disease

(2020) Margarita Papatheodoridi et al.   JOURNAL OF HEPATOLOGY

Non-Invasive Assessment of Liver Disease in Patients with NAFLD

(2019) Laurent Castera et al.   GASTROENTEROLOGY

Prospective evaluation of a primary care referral pathway for patients with non-alcoholic fatty liver disease

(2019) Ankur Srivastava et al.   JOURNAL OF HEPATOLOGY

New sequential combinations of noninvasive fibrosis tests provide an accurate diagnosis of advanced fibrosis in NAFLD

(2019) Jérôme Boursier et al.   JOURNAL OF HEPATOLOGY

Cost-comparison analysis of FIB-4, ELF and fibroscan in community pathways for non-alcoholic fatty liver disease

(2019) Ankur Srivastava et al.   BMC GASTROENTEROLOGY

Screening for therapeutic trials and treatment indication in clinical practice: MACK-3, a new blood test for the diagnosis of fibrotic NASH

(2018) J. Boursier et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016–2030

(2018) Chris Estes et al.   JOURNAL OF HEPATOLOGY

Long-term prognostic value of the FibroTest in patients with non-alcoholic fatty liver disease, compared to chronic hepatitis C, B, and alcoholic liver disease

(2018) Mona Munteanu et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Accuracy of Non-invasive Scoring Systems in Assessing Risk of Death and Liver-related Endpoints in Patients With Non-alcoholic Fatty Liver Disease

(2018) Hannes Hagström et al.   Clinical Gastroenterology and Hepatology

Comparison of laboratory tests, ultrasound, or magnetic resonance elastography to detect fibrosis in patients with nonalcoholic fatty liver disease: A meta-analysis

(2017) Guangqin Xiao et al.   HEPATOLOGY

The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases

(2017) Naga Chalasani et al.   HEPATOLOGY

Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention

(2017) Zobair Younossi et al.   Nature Reviews Gastroenterology & Hepatology

Diagnostic accuracy and prognostic significance of blood fibrosis tests and liver stiffness measurement by FibroScan in non-alcoholic fatty liver disease

(2016) Jérôme Boursier et al.   JOURNAL OF HEPATOLOGY

EASL–EASD–EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease

(2016)   JOURNAL OF HEPATOLOGY

Screening diabetic patients for non-alcoholic fatty liver disease with controlled attenuation parameter and liver stiffness measurements: a prospective cohort study

(2015) Raymond Kwok et al.   GUT

Utility and appropriateness of the fatty liver inhibition of progression (FLIP) algorithm and steatosis, activity, and fibrosis (SAF) score in the evaluation of biopsies of nonalcoholic fatty liver disease

(2014) Pierre Bedossa et al.   HEPATOLOGY

Comparing two correlated C indices with right-censored survival outcome: a one-shot nonparametric approach

(2014) Le Kang et al.   STATISTICS IN MEDICINE

Simple Noninvasive Systems Predict Long-term Outcomes of Patients With Nonalcoholic Fatty Liver Disease

(2013) Paul Angulo et al.   GASTROENTEROLOGY

MissForest--non-parametric missing value imputation for mixed-type data

(2011) D. J. Stekhoven et al.   BIOINFORMATICS

Non-invasive evaluation of liver fibrosis using transient elastography

(2008) Laurent Castera et al.   JOURNAL OF HEPATOLOGY

Exceeding the limits of liver histology markers

(2008) Shruti H. Mehta et al.   JOURNAL OF HEPATOLOGY